Y. Matsui

发表

Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors.

Mizuki Takahashi, K. Tamaki, Y. Mori, 2012, Bioorganic & medicinal chemistry letters.

Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARγ partial agonists.

K. Wakabayashi, Shinko Hayashi, J. Ohsumi, 2012, Bioorganic & medicinal chemistry letters.

Nouveaux anticorps anti-dr5

Y. Matsui, T. Takizawa, Toshiaki Ohtsuka, 2011 .

Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists.

K. Wakabayashi, Shinko Hayashi, H. Hanzawa, 2015, Bioorganic & medicinal chemistry letters.

Sequence-Specific Suppression of mdr1a/1b Expression in Mice via RNA Interference

Y. Takakura, M. Nishikawa, Y. Matsui, 2005, Pharmaceutical Research.

Vector-Based in Vivo RNA Interference: Dose- and Time-Dependent Suppression of Transgene Expression

K. Taira, M. Miyagishi, Y. Takakura, 2004, Journal of Pharmacology and Experimental Therapeutics.

Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor.

Mizuki Takahashi, K. Tamaki, K. Chiba, 2012, ACS medicinal chemistry letters.

Rh(I)-catalyzed intramolecular [2 + 2 + 1] cycloaddition of allenenes: Construction of bicyclo[4.3.0]nonenones with an angular methyl group and tricyclo[6.4.0.01,5]dodecenone

F. Inagaki, Y. Hayashi, C. Mukai, 2011, Beilstein journal of organic chemistry.

Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold.

Makoto Suzuki, H. Inoue, K. Nakayama, 2019, ACS medicinal chemistry letters.

Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.

K. Wakabayashi, Shinko Hayashi, J. Ohsumi, 2010, Bioorganic & medicinal chemistry letters.

The regulation of glucose and lipid homeostasis via PLTP as a mediator of BAT–liver communication

S. Kajimura, Mark P. Jedrychowski, D. Nomura, 2020, EMBO reports.

Effect of Interferon-γ on the Pharmacokinetics of Digoxin, a P-glycoprotein Substrate, Intravenously Injected into the Mouse

Y. Takakura, Y. Matsui, H. Kawaguchi, 2004, Journal of Pharmacology and Experimental Therapeutics.

Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification.

Hideki Yamamoto, J. Ohsumi, N. Watanabe, 2018, Bioorganic & medicinal chemistry.

Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization.

Hideki Yamamoto, J. Ohsumi, N. Watanabe, 2018, Bioorganic & medicinal chemistry.

Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator.

O. Ubukata, H. Hanzawa, K. Kanai, 2017, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPARγ modulators.

K. Wakabayashi, Shinko Hayashi, J. Ohsumi, 2012, European journal of medicinal chemistry.

A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1.

Yutaka Ikeno, O. Ubukata, H. Hanzawa, 2018, Acta crystallographica. Section F, Structural biology communications.

Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals

Y. Oda, T. Agatsuma, K. Inaki, 2022, Journal of oncology.

A promiscuous fatty acid ω-hydroxylase CYP94A90 is likely involved in biosynthesis of a floral nitro compound in loquat (Eriobotrya japonica).

Y. Asano, H. Matsuura, Takuya Yamaguchi, 2021, The New phytologist.